The Research and Development Team at Gilboa Therapeutics focuses on advancing innovative T cell therapies for solid tumors. This multidisciplinary team, led by the R&D Director and supported by experts in immunology and scientific research, collaborates to conduct preclinical studies, optimize therapeutic strategies, and translate findings into effective treatments, driving the company's mission to improve patient outcomes in cancer care.
View all